Head-to-head · WeighScore
Collective vs Enhance MD
By GLP-1 ScorecardUpdated
Score comparison
Enhance MD has the higher recorded score — 84.8/100 to 71.6/100.
Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enhance MD pairs compounded injections with advertised lab testing and care; its four-week supply and 48-week longer plan require a different budget from calendar-month pricing.
Before you choose
Before comparing the headline prices, the Collective review and the Enhance MD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Collective vs Invigor Medical and CoreAge Rx vs Enhance MD compare each of them with another graded program, and the list of alternatives to Collective ranks the programs closest to Collective on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Collective | Enhance MD |
|---|---|---|
| WeighScore | 71.6/100 | 84.8/100 |
| Grade | C | B |
| Site position | #66 | #14 |
| Semaglutide | $59/mo (plus a required $199/year membership that renews annually) | $249 every 4 weeks on the shortest Core plan; from $212 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge) |
| Tirzepatide | $69/mo (plus a required $199/year membership that renews annually) | $329 every 4 weeks on the shortest Advanced plan; from $280 per 4-week equivalent on a 48-week billed plan (confirm first-order promotion and charge) |
| Coverage | 44 states; excludes AL, CA, LA, MA, MS and WA | FAQ lists 40 states plus DC, subject to product availability; confirm treatment, clinician and pharmacy for your address |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #66 · C
Strengths
- Publishes flat medication prices across doses
- Membership includes doctor messaging, ongoing check-ins and nutrition support
- Express cold shipping is included
- A 21-day membership trial is available; medication remains payable
- Publishes the six states it does not currently serve
What to consider
- The $199 annual membership is additional to medication
- Membership renews automatically each year; fees generally are not refundable, including unused portions
- Terms permit a prescription-transmission technology fee without pricing it
- The reviewed public pages do not name the dispensing pharmacy
- The reviewed pricing does not define a medication month as a calendar month or a four-week cycle
Site position #14 · B
Strengths
- Core and Advanced publish separate short- and longer-plan prices with billing periods stated
- Product pages advertise care, coaching, supplies and six-month labs; baseline labs are described in onboarding
- Terms identify independent medical groups and possible pharmacies rather than only a generic provider network
- The FAQ publishes a product-availability state list and a clinical-ineligibility initial-payment refund policy
What to consider
- Four-week billing and a 48-week longer plan are not twelve calendar-month payments
- First-order discounts differ by term; actual debit, dose, quantity and ongoing schedule require confirmation
- An unused-prepaid-balance refund formula and precise refill cancellation cutoff were not established
- Pharmacy lists differ across public documents; the assigned dispenser and prescriber remain unknown
- One disclosed pharmacy has a closed Oklahoma nonresident permit; this limited finding does not establish company closure or the pharmacy assigned to a patient
- Elite combination and microdose benefit claims were not independently established; no branded or oral GLP-1 offer was established in the reviewed menu
Featured provider
Collective
Collective scores 71.6/100 (C). Collective pairs $59 semaglutide and $69 tirzepatide with a required $199 annual membership, with care messaging and cold shipping included.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.